Will lenacapavir be FDA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Will Gilead Sciences stock price increase by 20% or more by end of 2024? | Binary | | | 4 months ago | |
Will lenacapavir be EMA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Sunlenca available to consumers by Q1 2025? | Binary | | | 6 months ago | |
Gilead's stock price increases by 10% by Q3 2024? | Binary | | | 6 months ago | |
FDA Approval of Sunlenca by end of 2024? | Binary | | | 6 months ago | |
Will Sunlenca be FDA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Will Gilead's stock price increase by more than 20% by end of 2024? | Binary | | | 6 months ago | |
Will FDA approve Trodelvy for ES-SCLC by end of 2025? | Binary | | | 5 days ago | |
Will Gilead's lenacapavir receive FDA approval by December 31, 2025? | Binary | | | 10 days ago | |
Will Harvard's gene therapy for Diamond-Blackfan Anemia receive FDA approval by end of 2025? | Binary | | | 1 month ago | |
Marburg outbreak in Rwanda declared over by WHO by December 31, 2024? | Binary | | | 3 months ago | |
Marburg virus outbreak in Rwanda declared over by WHO by December 31, 2024? | Binary | | | 3 months ago | |
Marburg virus spread to neighboring countries of Rwanda by January 31, 2025? | Binary | | | 3 months ago | |
Will Livdelzi receive full FDA approval by August 14, 2025? | Binary | | | 4 months ago | |
Will Sunlenca be added to WHO's List of Essential Medicines by mid-2025? | Binary | | | 6 months ago | |
Gilead Sciences announces major partnership for Trodelvy distribution by mid-2025 | Binary | | | 6 days ago | |
Gilead Sciences announce new Trodelvy bladder cancer trial by mid-2025? | Binary | | | 2 months ago | |
Gilead Sciences reapply for Trodelvy bladder cancer approval by end of 2025? | Binary | | | 2 months ago | |
Gilead stock price increase by more than 5% by end of 2024? | Binary | | | 2 months ago | |
Rwanda reports more than 50 Marburg cases by December 31, 2024? | Binary | | | 3 months ago | |
Confirmed Marburg virus case in Germany by December 31, 2024? | Binary | | | 3 months ago | |
Rwanda begins human vaccine trials for Marburg virus by March 31, 2025? | Binary | | | 3 months ago | |
Will Gilead announce additional voluntary licensing agreements for lenacapavir by June 30, 2025? | Binary | | | 3 months ago | |
Will Gilead's stock price increase by 10% or more by the end of 2024? | Binary | | | 3 months ago | |
Will Gilead's stock price increase by at least 10% within one week of FDA approval of Lenacapavir? | Binary | | | 3 months ago | |
Will Gilead's Lenacapavir receive FDA approval for HIV prevention by end of 2024? | Binary | | | 3 months ago | |
Will Livdelzi achieve $500M in sales by August 14, 2025? | Binary | | | 4 months ago | |
What will Gilead's market valuation be by August 14, 2025? | Categorical | | | 4 months ago | |
Will Gilead's stock price increase by 10% or more by September 14, 2024? | Binary | | | 4 months ago | |
Will Livdelzi achieve $500 million in sales by end of 2024? | Binary | | | 4 months ago | |
Will Gilead Sciences' total revenue for Q3 2024 exceed $7 billion? | Binary | | | 5 months ago | |
What will be Gilead Sciences' Biktarvy sales for full-year 2024? | Categorical | | | 5 months ago | |
Will Gilead Sciences' stock price increase by at least 5% by the end of Q3 2024? | Binary | | | 5 months ago | |
Will Gilead Sciences' adjusted EPS for Q3 2024 exceed $2.00? | Binary | | | 5 months ago | |
What will be Gilead Sciences' adjusted EPS for full-year 2024? | Categorical | | | 5 months ago | |
Which company will introduce a competing HIV prevention drug by end of 2024? | Categorical | | | 6 months ago | |
Sunlenca vs. Truvada market share by end of 2025? | Categorical | | | 6 months ago | |
What will be Sunlenca's market share in HIV prevention drugs by end of 2024? | Categorical | | | 6 months ago | |
Will Trodelvy show significant improvement in ES-SCLC clinical trials by end of 2025? | Binary | | | 5 days ago | |
What will be Trodelvy's market position in ES-SCLC treatment by end of 2025? | Categorical | | | 5 days ago | |
What will be Trodelvy's impact on ES-SCLC patient survival rates by end of 2025? | Categorical | | | 5 days ago | |
Will Trodelvy receive accelerated approval for ES-SCLC by mid-2025? | Binary | | | 5 days ago | |
What will be the FDA's decision on Trodelvy for ES-SCLC by end of 2025? | Categorical | | | 5 days ago | |
Will FDA approve Lenacapavir for HIV prevention by mid-2025? | Binary | | | 6 days ago | |
Will WHO recommend Lenacapavir for HIV prevention by end of 2025? | Binary | | | 6 days ago | |
What percentage of the 2 million target will be reached with Lenacapavir by end of 2025? | Categorical | | | 6 days ago | |
Which country will first approve Lenacapavir for HIV prevention by end of 2025? | Categorical | | | 6 days ago | |
What will be the primary funding source for Lenacapavir distribution by end of 2025? | Categorical | | | 6 days ago | |
Will Lenacapavir reach 1 million people for HIV prevention by end of 2025? | Binary | | | 6 days ago | |
FDA approval of Trodelvy for advanced NSCLC with EGFR mutations by end of 2025 | Binary | | | 6 days ago | |
Gilead Sciences stock price change post-FDA approval of Trodelvy for NSCLC by end of 2025 | Categorical | | | 6 days ago | |
FDA approval of Trodelvy for extensive-stage small cell lung cancer by end of 2025 | Binary | | | 6 days ago | |
First major market to approve Trodelvy for NSCLC with EGFR mutations by end of 2025 | Categorical | | | 6 days ago | |
Number of new clinical trials for Trodelvy initiated in 2025 | Categorical | | | 6 days ago | |
Which company will announce a capsid inhibitor similar to lenacapavir by end of 2025? | Categorical | | | 8 days ago | |
Will lenacapavir receive WHO prequalification status by end of 2025? | Binary | | | 8 days ago | |
Will EMA approve lenacapavir for PrEP by end of 2025? | Binary | | | 8 days ago | |
Will lenacapavir be added to US CDC HIV prevention guidelines by end of 2025? | Binary | | | 8 days ago | |
Which region will approve lenacapavir for HIV prevention first by end of 2025? | Categorical | | | 8 days ago | |
Which demographic will see the first expanded use of lenacapavir as PrEP by end of 2025? | Categorical | | | 8 days ago | |
Will 5 African countries adopt Lenacapavir for HIV prevention by 2026? | Binary | | | 8 days ago | |
What will be the regulatory approval status of Lenacapavir by end of 2025? | Categorical | | | 8 days ago | |
How many countries will implement Lenacapavir by 2026? | Categorical | | | 8 days ago | |
Where will Lenacapavir launch first by end of 2025? | Categorical | | | 8 days ago | |
Will Lenacapavir receive FDA approval by end of 2025? | Binary | | | 8 days ago | |
Will Lenacapavir be on WHO's essential medicines list by 2026? | Binary | | | 8 days ago | |
Will lenacapavir be included in the WHO Essential Medicines list by 2025? | Binary | | | 10 days ago | |
Will Gilead announce a price reduction for lenacapavir in middle-income countries by 2025? | Binary | | | 10 days ago | |
What will be the adoption rate of lenacapavir in high-income countries by 2025? | Categorical | | | 10 days ago | |
What will be lenacapavir's impact on global HIV infection rates by 2025? | Categorical | | | 10 days ago | |
How many countries will adopt generic lenacapavir by 2025? | Categorical | | | 10 days ago | |
Will lenacapavir be added to the WHO's list of essential medicines by the end of 2025? | Binary | | | 11 days ago | |
Will Gilead reduce lenacapavir prices in middle-income countries by the end of 2025? | Binary | | | 11 days ago | |
Which country will first approve lenacapavir for public use by the end of 2025? | Categorical | | | 11 days ago | |
What will be the reduction in new HIV infections due to lenacapavir by the end of 2026? | Categorical | | | 11 days ago | |
How many countries will have approved generic versions of lenacapavir by the end of 2026? | Categorical | | | 11 days ago | |
Will lenacapavir receive FDA approval for HIV prevention by the end of 2025? | Binary | | | 11 days ago | |
How many countries will approve lenacapavir for HIV prevention by end of 2025? | Categorical | | | 26 days ago | |
Will lenacapavir receive FDA approval for HIV prevention by end of 2024? | Binary | | | 26 days ago | |
Will lenacapavir be commercially available for HIV prevention in the US by mid-2025? | Binary | | | 26 days ago | |
Will additional Phase 3 trial results for lenacapavir be published in a peer-reviewed journal by end of 2024? | Binary | | | 26 days ago | |
What will be the market share of lenacapavir in HIV prevention compared to daily oral PrEP by end of 2025? | Categorical | | | 26 days ago | |
How will lenacapavir's effectiveness compare across demographic groups by end of 2024? | Categorical | | | 26 days ago | |
Will Intellia's CRISPR treatment for ATTR enter Phase 2 trials by end of November 2025? | Binary | | | 1 month ago | |
What will be the outcome of Gilead's Livdelzi Phase 3 study for PBC by end of 2024? | Categorical | | | 1 month ago | |
What will be the dominant therapeutic approach for Diamond-Blackfan Anemia by 2026? | Categorical | | | 1 month ago | |
What will be the primary outcome of Intellia's CRISPR treatment Phase 1 study for ATTR by end of 2024? | Categorical | | | 1 month ago | |
Will Gilead's Livdelzi launch commercially in the US by mid-2025? | Binary | | | 1 month ago | |
Trodelvy receive new FDA approval for different cancer by end of 2025? | Binary | | | 2 months ago | |
Gilead Sciences prioritize Trodelvy market expansion region by end of 2025? | Categorical | | | 2 months ago | |
Next major FDA regulatory action on Trodelvy by end of 2025? | Categorical | | | 2 months ago | |
Next Gilead Sciences partner for Trodelvy development by end of 2025? | Categorical | | | 2 months ago | |
Outcome of TROPiCS-04 study publication by mid-2025? | Categorical | | | 2 months ago | |
Gilead to announce new Trodelvy trial in urothelial cancer by mid-2025? | Binary | | | 2 months ago | |
FDA statement on Trodelvy withdrawal by end of 2024? | Binary | | | 2 months ago | |
Primary reason for Trodelvy withdrawal in urothelial cancer? | Categorical | | | 2 months ago | |
First company to announce new urothelial cancer treatment post-Trodelvy withdrawal? | Categorical | | | 2 months ago | |
Marburg vaccine availability in Rwanda by December 31, 2024? | Categorical | | | 3 months ago | |
Country with highest Marburg cases by June 30, 2025? | Categorical | | | 3 months ago | |